Published in Liver Transpl on October 01, 2005
Daclizumab induction therapy in liver transplant recipients with renal insufficiency. Aliment Pharmacol Ther (2010) 1.40
Antibody immunosuppressive therapy in solid-organ transplant: Part I. MAbs (2011) 1.24
Current concepts and perspectives of immunosuppression in organ transplantation. Langenbecks Arch Surg (2007) 0.94
A therapeutic exploratory study to determine the efficacy and safety of calcineurin-inhibitor-free de-novo immunosuppression after liver transplantation: CILT. BMC Surg (2010) 0.78
Liver transplantation: Current status and challenges. World J Gastroenterol (2016) 0.76
Renal-sparing immunosuppressive protocol using OKT3 after liver transplantation: a 19-year single-institution experience. Proc (Bayl Univ Med Cent) (2011) 0.76
Living donor liver transplantation in Taiwan-challenges beyond surgery. Hepatobiliary Surg Nutr (2016) 0.75
The Impact of Therapeutic Antibodies on the Management of Digestive Diseases: History, Current Practice, and Future Directions. Dig Dis Sci (2017) 0.75
Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy. Anesthesiology (2006) 3.09
Clinical characteristics and prognostic factors of splenic abscess: a review of 67 cases in a single medical center of Taiwan. World J Gastroenterol (2006) 2.41
Association between hypertensive disorders during pregnancy and end-stage renal disease: a population-based study. CMAJ (2013) 2.34
Difficult ventilation with a double-lumen endotracheal tube: an unusual manufacturing defect. Anesth Analg (2005) 2.14
Living donor liver transplantation: the Asian perspective. Transplantation (2014) 2.13
Epidemiological features of biliary atresia in Taiwan, a national study 1996-2003. J Gastroenterol Hepatol (2007) 1.72
The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients. Eur J Cancer (2008) 1.71
Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. J Hepatol (2010) 1.67
Resection of large hepatocellular carcinoma using the combination of liver hanging maneuver and anterior approach. World J Surg (2010) 1.64
Is the Cancer of the Liver Italian Program system an adequate weighting for survival of hepatocellular carcinoma? Evaluation of intrascore prognostic value among 36 subgroups. Liver Int (2008) 1.63
Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: analysis of 5,613 cases from a medical center in southern Taiwan. Int J Cancer (2007) 1.54
Surgical resection improves the survival of selected hepatocellular carcinoma patients in Barcelona clinic liver cancer stage C. Dig Liver Dis (2012) 1.52
Perioperative factors affecting long-term outcomes of 473 consecutive patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg Oncol (2009) 1.46
Ethical perspectives on living donor organ transplantation in Asia. Liver Transpl (2009) 1.46
Massive pulmonary embolism presented as sudden cardiac arrest in the immediate postoperative period after laparoscopic hysterectomy. J Clin Anesth (2003) 1.42
Arterial reconstruction in hepatic artery occlusions in adult living donor liver transplantation using gastric vessels. Surgery (2008) 1.40
Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis. Eur J Cancer (2010) 1.34
Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma. J Hepatol (2011) 1.27
Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma. Cancer Res (2002) 1.22
Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model. Transplantation (2009) 1.18
Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients. J Surg Oncol (2008) 1.13
Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25-35. Obes Surg (2011) 1.13
Single incision transumbilical laparoscopic Roux-en-Y gastric bypass: a first case report. Obes Surg (2009) 1.10
Stress response to hepatectomy in patients with a healthy or a diseased liver. World J Surg (2003) 1.10
Preliminary surgical results of single-incision transumbilical laparoscopic bariatric surgery. Obes Surg (2010) 1.10
Giant cavernous hemangioma of the liver with coagulopathy: adult Kasabach-Merritt syndrome. Surgery (2007) 1.09
A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer. Cancer Immunol Immunother (2003) 1.09
Clinical analysis of primary duodenal adenocarcinoma: an 11-year experience. J Gastroenterol Hepatol (2007) 1.08
Ethics and rationale of living-donor liver transplantation in Asia. Transplantation (2003) 1.07
Modulation of immune response and T-cell regulation by donor adipose-derived stem cells in a rodent hind-limb allotransplant model. Plast Reconstr Surg (2011) 1.06
Retromammary approach for endoscopic resection of benign breast lesions. World J Surg (2009) 1.04
Primary hepatic carcinoid tumor: a case report and review of the literature. Cases J (2009) 1.03
Tumor lysis syndrome after transarterial chemoembolization of hepatocellular carcinoma: case reports and literature review. World J Gastroenterol (2009) 1.02
Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection. Oncol Rep (2007) 1.01
Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis. J Hepatol (2012) 1.01
Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival. J Gastroenterol (2008) 1.01
Validation of the 7th edition TNM staging system for hepatocellular carcinoma: an analysis of 8,828 patients in a single medical center. Dig Dis Sci (2013) 1.01
Anatomical and technical aspects of hepatic artery reconstruction in living donor liver transplantation. Surgery (2006) 1.00
Long-term results of a randomized, observation-controlled, phase III trial of adjuvant interferon Alfa-2b in hepatocellular carcinoma after curative resection. Ann Surg (2012) 1.00
Hypertensive disorders in pregnancy and subsequent diabetes mellitus: a retrospective cohort study. Am J Med (2012) 0.99
Prognostic value of acute physiology and chronic health evaluation II and organ system failure in patients with acute renal failure requiring dialysis. Ren Fail (2005) 0.99
Expression of toll-like receptors and type 1 interferon specific protein MxA in biliary atresia. Lab Invest (2006) 0.98
Characterization of liver enzymes on living related liver transplantation patients with acute rejection. Hepatogastroenterology (2005) 0.98
Early stage of biliary atresia is associated with significant changes in 8-hydroxydeoxyguanosine and mitochondrial copy number. J Pediatr Gastroenterol Nutr (2007) 0.97
Laparoscopic Roux-en-Y gastric bypass for morbidly obese Chinese patients: learning curve, advocacy and complications. Obes Surg (2008) 0.97
Liver resection for benign liver tumors: indications and outcome. Am J Surg (2007) 0.96
Homogenous phenomenon of graft liver CYP2C19 genotypes after living donor liver transplantation. Eur J Clin Invest (2011) 0.96
Rhabdomyolysis, acute renal failure, and multiple focal neuropathies after drinking alcohol soaked with centipede. Ren Fail (2004) 0.95
Intraoperative blood loss is a risk factor for complications in donors after living donor hepatectomy. Liver Transpl (2006) 0.95
Influence of CYP2C19 genotypes on graft pathological findings and postoperative liver function in recipients after living-donor liver transplantation. Ann Transplant (2010) 0.95
Donor graft does not affect the P450 2C19 genotype expressed in peripheral blood in recipients of living donor liver transplantation. Clin Transplant (2010) 0.95
Routine microsurgical biliary reconstruction decreases early anastomotic complications in living donor liver transplantation. Liver Transpl (2009) 0.95
A novel surgical technique: single-incision transumbilical laparoscopic Roux-en-Y gastric bypass. Obes Surg (2010) 0.95
Evaluation of living liver donors. Transplantation (2003) 0.95
Serum levels of hepatocyte growth factor in patients with breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 0.95
Diagnostic sensitivity of hepatocellular carcinoma imaging and its application to non-cirrhotic patients. J Gastroenterol Hepatol (2011) 0.95
Expanded-spectrum beta-lactamase producing Klebsiella pneumoniae-related peritonitis in a patient on peritoneal dialysis. Am J Kidney Dis (2004) 0.94
Right lobe living donor liver transplantation-addressing the middle hepatic vein controversy. Ann Surg (2003) 0.94
Propofol pretreatment attenuates LPS-induced granulocyte-macrophage colony-stimulating factor production in cultured hepatocytes by suppressing MAPK/ERK activity and NF-kappaB translocation. Toxicol Appl Pharmacol (2008) 0.94
Connectivity of default-mode network is associated with cerebral edema in hepatic encephalopathy. PLoS One (2012) 0.93
Emergency splenic arterial embolization for massive variceal bleeding in liver recipient with left-sided portal hypertension. Liver Transpl (2005) 0.93
Hepatoma-derived growth factor is a novel prognostic factor for gastrointestinal stromal tumors. Int J Cancer (2007) 0.93
Clinical distinction and evaluation of leptospirosis in Taiwan--a case-control study. J Nephrol (2005) 0.93
Intrathecal administration of roscovitine inhibits Cdk5 activity and attenuates formalin-induced nociceptive response in rats. Acta Pharmacol Sin (2005) 0.92